Supporting the Physiatrist, Strengthening the Specialty

AAPM&R is working to ensure PM&R is positioned to thrive in the future of healthcare and that you’re prepared for wherever your career takes you. Our more than 10,000 Academy members support each other in advancing PM&R’s impact through healthcare. As we move forward, it is more important than ever that every member play an active role in helping one another realize the vision for our specialty.

Explore Our Annual Report

Join Our PM&R Community

Newsroom

Looking for AAPM&R members in the news? Press releases? Our Academy Action Center? Or looking to submit your members in the news content? You'll find it all in our Newsroom. You will also be able to explore PM&R and Academy news as well as learn how to contact us if you would like to submit your member content, or if you are a reporter who is interested in speaking with a PM&R physician.

Learn More

Event Calendar and Webinars

Stay up to date on all Academy events and learning opportunities and view recordings of past webinars.

View Upcoming Events

PM&R Aspire

PM&R Aspire is our career-exploration platform purpose-built to help PM&R professionals make better-informed career decisions. We have mapped employer locations across the United States, enabling you to explore, message and apply to the roles that matter most to you.

Learn More

PM&R Q&A Video Conversations

AAPM&R is leading the advancement of physiatry’s impact throughout healthcare as aligned with YOUR vision for the specialty. Explore our Q&A video series where members of our Physiatrist in Training (PHiT) Council Board chat with AAPM&R Board leaders.

Learn More

Latest News

Opportunity to Submit Comments to AHRQ Regarding Two Draft Reports on Treatments for Acute Pain

Sep 10, 2020, 16:54 by User Not Found

The Agency for Healthcare Research and Quality (AHRQ) is interested in receiving public comments on two draft reports, Treatments for Acute Pain: A Systematic Review and Acute Treatments for Episodic Migraine.

Treatments for Acute Pain: A Systematic Review – This report evaluates the effectiveness and comparative effectiveness of opioid, nonopioid pharmacologic, and nonpharmacologic therapy in patients with specific types of acute pain, including effects on pain, function, quality of life, adverse events, and long-term use of opioids. Overall, AHRQ found that opioids were less effective than nonopioid analgesics for some acute pain conditions and were associated with increased risk of short-term adverse events. Public comments for this report may be submitted here.
Acute Treatments for Episodic Migraine – This report evaluates the effectiveness and comparative effectiveness of pharmacologic and non-pharmacologic therapies for the acute treatment of episodic migraine in adults. Overall, AHRQ asserts that a number of acute treatments for episodic migraine exist with varying degrees of evidence for effectiveness and harms. Use of triptans, NSAIDs, antiemetics, dihydroergotamine, calcitonin gene-related peptide (CGRP) antagonists, and lasmiditan is associated with improved pain and function. Public comment for this report may be submitted here.

Opportunity to Submit Comments to AHRQ Regarding Two Draft Reports on Treatments for Acute Pain

Sep 10, 2020, 16:54 by User Not Found

Treatments for Acute Pain: A Systematic Review – This report evaluates the effectiveness and comparative effectiveness of opioid, nonopioid pharmacologic, and nonpharmacologic therapy in patients with specific types of acute pain, including effects on pain, function, quality of life, adverse events, and long-term use of opioids. Overall, AHRQ found that opioids were less effective than nonopioid analgesics for some acute pain conditions and were associated with increased risk of short-term adverse events. Public comments for this report may be submitted here.
Acute Treatments for Episodic Migraine – This report evaluates the effectiveness and comparative effectiveness of pharmacologic and non-pharmacologic therapies for the acute treatment of episodic migraine in adults. Overall, AHRQ asserts that a number of acute treatments for episodic migraine exist with varying degrees of evidence for effectiveness and harms. Use of triptans, NSAIDs, antiemetics, dihydroergotamine, calcitonin gene-related peptide (CGRP) antagonists, and lasmiditan is associated with improved pain and function. Public comment for this report may be submitted here.

View All News

Explore AAPM&R

Register for #AAPMR26

Online Learning Portal

Education is a fundamental offering that affects PM&R physicians across clinical focuses, practice areas, career stages and levels of expertise. As part of Academy membership, we provide top-notch education and other innovative learning resources across a variety of delivery mechanisms.

Access AAPM&R’s popular Online Learning Portal, which features educational resources, including case studies, instructional videos and more on a variety of clinical and practice topics.

Learn More

Online Learning Portal

Online Education Subscription

24/7 access to our online educational resources through the end of your annual membership cycle. Check out what's included below!

Learn More

STEP Certificate Programs

AAPM&R’s highly-regarded STEP Certificate Programs are designed by physiatrists for physiatrists and teach and assess important physiatric skills using a progressive, competency- based curriculum.

Learn More

PhyzForum

PhyzForum is an online physiatry community that allows you to engage with peers, ask advice, and share experiences. Participate in discussions to network, collaborate, and exchange best practices with your peers.

Learn More

Annual Assembly
November 12-15

The 2020 Annual Assembly is virtual! Join us from November 12-15 as we meet online to share best practices and support each other as we navigate a “new normal."

Learn More

Critical Conversation Series

Thursday, October 1 at 6 pm (CT)

You're invited to participate in a series of discussions on racial equity, access and inclusion in today’s world. Join us for our next conversation on October 1 for AAPM&R's Diversity and Inclusion Journey. We will review efforts that led to the creation of the D&I strategic plan, unveil our new Principles of Inclusion and Engagement and share new initiatives on the horizon.

Learn More

AAPM&R News

Opportunity to Submit Comments to AHRQ Regarding Two Draft Reports on Treatments for Acute Pain

Sep 10, 2020

Treatments for Acute Pain: A Systematic Review – This report evaluates the effectiveness and comparative effectiveness of opioid, nonopioid pharmacologic, and nonpharmacologic therapy in patients with specific types of acute pain, including effects on pain, function, quality of life, adverse events, and long-term use of opioids. Overall, AHRQ found that opioids were less effective than nonopioid analgesics for some acute pain conditions and were associated with increased risk of short-term adverse events. Public comments for this report may be submitted here.
Acute Treatments for Episodic Migraine – This report evaluates the effectiveness and comparative effectiveness of pharmacologic and non-pharmacologic therapies for the acute treatment of episodic migraine in adults. Overall, AHRQ asserts that a number of acute treatments for episodic migraine exist with varying degrees of evidence for effectiveness and harms. Use of triptans, NSAIDs, antiemetics, dihydroergotamine, calcitonin gene-related peptide (CGRP) antagonists, and lasmiditan is associated with improved pain and function. Public comment for this report may be submitted here.

Physiatry News

Opportunity to Submit Comments to AHRQ Regarding Two Draft Reports on Treatments for Acute Pain

Sep 10, 2020

Treatments for Acute Pain: A Systematic Review – This report evaluates the effectiveness and comparative effectiveness of opioid, nonopioid pharmacologic, and nonpharmacologic therapy in patients with specific types of acute pain, including effects on pain, function, quality of life, adverse events, and long-term use of opioids. Overall, AHRQ found that opioids were less effective than nonopioid analgesics for some acute pain conditions and were associated with increased risk of short-term adverse events. Public comments for this report may be submitted here.
Acute Treatments for Episodic Migraine – This report evaluates the effectiveness and comparative effectiveness of pharmacologic and non-pharmacologic therapies for the acute treatment of episodic migraine in adults. Overall, AHRQ asserts that a number of acute treatments for episodic migraine exist with varying degrees of evidence for effectiveness and harms. Use of triptans, NSAIDs, antiemetics, dihydroergotamine, calcitonin gene-related peptide (CGRP) antagonists, and lasmiditan is associated with improved pain and function. Public comment for this report may be submitted here.

More News

Take the Next STEP in Your Ultrasound Education

AAPM&R's STEP Ultrasound Certificate Program is the premiere ultrasound training program—designed by physiatrists, for physiatrists.

As the only formal, standardized training pathway available for honing and validating your ultrasound skill set, successful completion of the STEP Ultrasound Program will clearly demonstrate to your patients, fellow health care professionals, employers, and the medical facilities you work with that you are a competent professional, expertly trained in ultrasound.

Learn More

Supporting the Physiatrist, Strengthening the Specialty

Newsroom